UOMi006-A

Registration Summary:

A P E C

AKLCS-hiPSC-PT6

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	UOMi006-A
Cite as:	UOMi006-A (RRID:CVCL_A7IN)
Alternative name(s)	AKLCS-hiPSC-PT6
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	23rd April 2021
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	University of Manitoba (UOM)
External Databases
Cellosaurus	CVCL_A7IN
Wikidata	Q107117352
General Information
Publications	Lester Sequiera G et al. Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome. Cells. 2021 Mar 5;10(3). Srivastava A et al. Human induced pluripotent stem cell (hiPSC) line UOMi006-A derived from PBMCs of a patient with Kearns-Sayre syndrome. Stem cell research. 2021 May;53:102355. Srivastava A et al. Establishment of a new human iPSC cell line (UOMi007-A) from a patient with Hypophosphatasia. Stem cell research. 2022 Aug;63:102839. Adelipour M et al. The role of autophagy in the metabolism and differentiation of stem cells. Biochimica et biophysica acta. Molecular basis of disease. 2022 Aug 1;1868(8):166412. Srivastava A et al. Reprogramming of Hypophosphatasia patient cells to generate a new human iPSC cell line (UOMi009-A). Stem cell research. 2022 Oct;64:102921. Srivastava A et al. Generation of new human iPSC cell line (UOMi008-A) from a Hypophosphatasia patient. Stem cell research. 2022 Oct;64:102891. Sareen N et al. Establishment of a new human iPSC cell line (UOMi012-A) from a patient with congenital heart defect who has undergone Fontan procedure. Stem cell research. 2024 Jul 28;80:103509.
* Is the cell line readily obtainable for third parties?	No

hIPSC Derivation

General